Finance

Lists
Why is BLISSGVS down 4,90%?
Dive Deeper
BLISSGVS:NSE
Bliss GVS Pharma Ltd
620,05 INR
-4,90%
(-31,95) 1D
19-окт., 15:30:00 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for BLISSGVS...
Open
662,50 INR
High
662,50 INR
Low
620,00 INR
Mkt. cap
65,96 млд
Avg. vol.
321,42 миң
Volume
118,22 миң
Dividend
0,24%
Quarterly dividend
0,38 INR
Ex-dividend date
2026-ж., 8-июл.
P/E ratio
49,18
52-wk high
739,90 INR
52-wk low
118,00 INR
EPS
12,61 INR
Shares outstanding
103,15 млн
No. of employees
1 миң
Open
662,50 INR
High
662,50 INR
Low
620,00 INR
Mkt. cap
65,96 млд
Avg. vol.
321,42 миң
Volume
118,22 миң
Dividend
0,24%
Quarterly dividend
0,38 INR
Ex-dividend date
2026-ж., 8-июл.
P/E ratio
49,18
52-wk high
739,90 INR
52-wk low
118,00 INR
EPS
12,61 INR
Shares outstanding
103,15 млн
No. of employees
1 миң
News stories
From web sources and news partners
About Bliss GVS Pharma Ltd
CEO-
Employees1,03 миң
Founded1984
Headquarters-
SectorPharmaceutical industry
Last report
2026-ж., 12-авг.
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
2,86 млд / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
2,44 млд
2,18 млд
2,57 млд
2,86 млд
Cost of goods sold
1,18 млд
1,02 млд
1,36 млд
1,14 млд
Cost of revenue
1,18 млд
1,02 млд
1,36 млд
1,14 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
333,51 млн
359,36 млн
1,00 млд
430,47 млн
Operating expense
1,03 млд
901,49 млн
844,80 млн
1,05 млд
Total operating expenses
2,21 млд
1,92 млд
2,21 млд
2,19 млд
Operating income
234,96 млн
264,40 млн
363,12 млн
664,63 млн
Other non operating income
201,78 млн
184,56 млн
-597,23 млн
96,00 млн
EBT including unusual items
406,33 млн
408,96 млн
449,50 млн
754,83 млн
EBT excluding unusual items
406,33 млн
434,09 млн
431,08 млн
754,83 млн
Income tax expense
120,44 млн
161,17 млн
79,51 млн
241,11 млн
Effective tax rate
29,64%
39,41%
17,69%
31,94%
Other operating expenses
612,37 млн
458,64 млн
-244,91 млн
516,84 млн
Net income
272,50 млн
232,66 млн
355,75 млн
500,97 млн
Net profit margin
11,15%
10,66%
13,84%
17,54%
Earnings per share
-
-
-
-
Interest and investment income
-
-
167,47 млн
-
Interest expense
-30,42 млн
-14,86 млн
-20,08 млн
-5,79 млн
Net interest expenses
-30,42 млн
-14,86 млн
147,40 млн
-5,79 млн
Depreciation and amortization charges
82,62 млн
83,50 млн
86,71 млн
99,38 млн
EBITDA
317,28 млн
326,86 млн
431,12 млн
732,63 млн
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google колдонмолору